Rainer Weber
Correlates of self-reported nonadherence to antiretroviral therapy in HIV-infected patients: the Swiss HIV Cohort Study
Glass T, Battegay M, Hirschel B, Cavassini M, Bernasconi E, Furrer H, Rickenbach M, Vernazza P, Weber R, De Geest S, Bucher H. Correlates of self-reported nonadherence to antiretroviral therapy in HIV-infected patients: the Swiss HIV Cohort Study. Journal of acquired immune deficiency syndromes (1999) 2006; 41:385-92.
Mar 1, 2006Correlates of self-reported nonadherence to antiretroviral therapy in HIV-infected patients: the Swiss HIV Cohort Study
Mar 1, 2006Journal of acquired immune deficiency syndromes (1999) 2006; 41:385-92
Glass Tracy R, Battegay Manuel, Hirschel Bernard, Cavassini Matthias, Bernasconi Enos, Furrer Hansjakob, Rickenbach Martin, Vernazza Pietro, Weber Rainer, De Geest Sabina, Bucher Heiner C
Eligibility for and outcome of hepatitis C treatment of HIV-coinfected individuals in clinical practice: the Swiss HIV cohort study
Zinkernagel A, Weber R, Schmid P, Bernasconi E, Opravil M, Tarr P, Hirschel B, Battegay M, Furrer H, Rickenbach M, Ledergerber B, von Wyl V, Swiss HIV Cohort Study. Eligibility for and outcome of hepatitis C treatment of HIV-coinfected individuals in clinical practice: the Swiss HIV cohort study. Antiviral therapy 2006; 11:131-42.
Jan 1, 2006Eligibility for and outcome of hepatitis C treatment of HIV-coinfected individuals in clinical practice: the Swiss HIV cohort study
Jan 1, 2006Antiviral therapy 2006; 11:131-42
Zinkernagel Annelies S, Weber Rainer, Schmid Patrick, Bernasconi Enos, Opravil Milos, Tarr Philip E, Hirschel Bernard, Battegay Manuel, Furrer Hansjakob, Rickenbach Martin, Ledergerber Bruno, von Wyl Viktor, Swiss HIV Cohort Study
Dose-dependent influence of didanosine on immune recovery in HIV-infected patients treated with tenofovir
Karrer U, Speck R, Weber R, Russotti M, Schmid P, Hirschel B, Gayet-Ageron A, Cavassini M, Battegay M, Elzi L, Furrer H, Ledergerber B, Swiss HIV Cohort Study. Dose-dependent influence of didanosine on immune recovery in HIV-infected patients treated with tenofovir. AIDS (London, England) 2005; 19:1987-94.
Nov 18, 2005Dose-dependent influence of didanosine on immune recovery in HIV-infected patients treated with tenofovir
Nov 18, 2005AIDS (London, England) 2005; 19:1987-94
Karrer Urs, Speck Roberto F, Weber Rainer, Russotti Marina, Schmid Patrick, Hirschel Bernard, Gayet-Ageron Angèle, Cavassini Matthias, Battegay Manuel, Elzi Luigia, Furrer Hansjakob, Ledergerber Bruno, Swiss HIV Cohort Study
Plasma leptin levels in men are not related to the development of lipoatrophy during antiretroviral therapy
Wunder D, Furrer H, Schmid P, Schiffer V, Bucher H, Cavassini M, Bernasconi E, Weber R, Fux C, Bersinger N, Swiss HIV Cohort Study. Plasma leptin levels in men are not related to the development of lipoatrophy during antiretroviral therapy. AIDS (London, England) 2005; 19:1837-42.
Nov 4, 2005Plasma leptin levels in men are not related to the development of lipoatrophy during antiretroviral therapy
Nov 4, 2005AIDS (London, England) 2005; 19:1837-42
Wunder Dorothea, Furrer Hansjakob, Schmid Patrick, Schiffer Véronique, Bucher Heiner C, Cavassini Matthias, Bernasconi Enos, Weber Rainer, Fux Christoph, Bersinger Nick A, Swiss HIV Cohort Study
Unsafe sex and increased incidence of hepatitis C virus infection among HIV-infected men who have sex with men: the Swiss HIV Cohort Study
Rauch A, Furrer H, Evison J, Zinkernagel A, Bernasconi E, Vernazza P, Bucher H, Tarr P, Hirschel B, Weber R, Rickenbach M, Swiss HIV Cohort Study. Unsafe sex and increased incidence of hepatitis C virus infection among HIV-infected men who have sex with men: the Swiss HIV Cohort Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005; 41:395-402.
Aug 1, 2005Unsafe sex and increased incidence of hepatitis C virus infection among HIV-infected men who have sex with men: the Swiss HIV Cohort Study
Aug 1, 2005Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005; 41:395-402
Rauch Andri, Furrer Hansjakob, Evison John, Zinkernagel Annelies S, Bernasconi Enos, Vernazza Pietro, Bucher Heiner C, Tarr Philip E, Hirschel Bernard, Weber Rainer, Rickenbach Martin, Swiss HIV Cohort Study
Pulmonary Mycobacterium sherrisii infection in a human immunodeficiency virus type 1-infected patient
Gämperli A, Bosshard P, Sigrist T, Brändli O, Wildermuth S, Weber R, Mueller N. Pulmonary Mycobacterium sherrisii infection in a human immunodeficiency virus type 1-infected patient. Journal of clinical microbiology 2005; 43:4283-5.
Aug 1, 2005Pulmonary Mycobacterium sherrisii infection in a human immunodeficiency virus type 1-infected patient
Aug 1, 2005Journal of clinical microbiology 2005; 43:4283-5
Gämperli Andrea, Bosshard Philipp P, Sigrist Thomas, Brändli Otto, Wildermuth Simon, Weber Rainer, Mueller Nicolas J
Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disorders
Tarr P, Telenti A, Ledergerber B, Rickenbach M, Darioli R, Bernasconi E, Vernazza P, Weber R, Battegay M, Hirschel B, Martinez R, Rotger M, Furrer H, Bleiber G, Taffé P, Swiss HIV Cohort Study. Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disorders. The Journal of infectious diseases 2005; 191:1419-26.
May 1, 2005Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disorders
May 1, 2005The Journal of infectious diseases 2005; 191:1419-26
Tarr Philip E, Telenti Amalio, Ledergerber Bruno, Rickenbach Martin, Darioli Roger, Bernasconi Enos, Vernazza Pietro, Weber Rainer, Battegay Manuel, Hirschel Bernard, Martinez Raquel, Rotger Margalida, Furrer Hansjakob, Bleiber Gabriela, Taffé Patrick, Swiss HIV Cohort Study
Body fat changes among antiretroviral-naive patients on PI- and NNRTI-based HAART in the Swiss HIV cohort study
Young J, Battegay M, Vernazza P, Tarr P, Hirschel B, Bernasconi E, Furrer H, Weber R, Rickenbach M, Bucher H. Body fat changes among antiretroviral-naive patients on PI- and NNRTI-based HAART in the Swiss HIV cohort study. Antiviral therapy 2005; 10:73-81.
Jan 1, 2005Body fat changes among antiretroviral-naive patients on PI- and NNRTI-based HAART in the Swiss HIV cohort study
Jan 1, 2005Antiviral therapy 2005; 10:73-81
Young Jim, Battegay Manuel, Vernazza Pietro, Tarr Philip E, Hirschel Bernard, Bernasconi Enos, Furrer Hansjakob, Weber Rainer, Rickenbach Martin, Bucher Heiner C
Lipid profiles for antiretroviral-naive patients starting PI- and NNRTI-based therapy in the Swiss HIV cohort study
Young J, Battegay M, Vernazza P, Tarr P, Hirschel B, Bernasconi E, Furrer H, Rickenbach M, Weber R, Bucher H. Lipid profiles for antiretroviral-naive patients starting PI- and NNRTI-based therapy in the Swiss HIV cohort study. Antiviral therapy 2005; 10:585-91.
Jan 1, 2005Lipid profiles for antiretroviral-naive patients starting PI- and NNRTI-based therapy in the Swiss HIV cohort study
Jan 1, 2005Antiviral therapy 2005; 10:585-91
Young Jim, Battegay Manuel, Vernazza Pietro, Tarr Philip E, Hirschel Bernard, Bernasconi Enos, Furrer Hansjakob, Rickenbach Martin, Weber Rainer, Bucher Heiner C
Humoral immunity to HIV-1: kinetics of antibody responses in chronic infection reflects capacity of immune system to improve viral set point
Trkola A, Günthard H, Bonhoeffer S, Hirschel B, Weber R, Bernasconi E, Vernazza P, Battegay M, Furrer H, Fagard C, Oxenius A, Leemann C, Kuster H, Swiss HIV Cohort Study. Humoral immunity to HIV-1: kinetics of antibody responses in chronic infection reflects capacity of immune system to improve viral set point. Blood 2004; 104:1784-92.
Sep 15, 2004Humoral immunity to HIV-1: kinetics of antibody responses in chronic infection reflects capacity of immune system to improve viral set point
Sep 15, 2004Blood 2004; 104:1784-92
Trkola Alexandra, Günthard Huldrych F, Bonhoeffer Sebastian, Hirschel Bernard, Weber Rainer, Bernasconi Enos, Vernazza Pietro, Battegay Manuel, Furrer Hansjakob, Fagard Catherine, Oxenius Annette, Leemann Christine, Kuster Herbert, Swiss HIV Cohort Study
Is unsafe sexual behaviour increasing among HIV-infected individuals?
Glass T, Bucher H, Battegay M, Hirschel B, Cavassini M, Weber R, Rickenbach M, Vernazza P, Young J, Swiss HIV Cohort Study. Is unsafe sexual behaviour increasing among HIV-infected individuals?. AIDS (London, England) 2004; 18:1707-14.
Aug 20, 2004Is unsafe sexual behaviour increasing among HIV-infected individuals?
Aug 20, 2004AIDS (London, England) 2004; 18:1707-14
Glass Tracy R, Bucher Heiner C, Battegay Manuel, Hirschel Bernard, Cavassini Matthias, Weber Rainer, Rickenbach Martin, Vernazza Pietro, Young Jim, Swiss HIV Cohort Study
Long-term virological response to multiple sequential regimens of highly active antiretroviral therapy for HIV infection
Kaufmann G, Battegay M, Hirschel B, Rickenbach M, Bernasconi E, Vernazza P, Ledergerber B, Cavassini M, Furrer H, Perrin L, Weber R, Khanna N, Swiss HIV Cohort Study. Long-term virological response to multiple sequential regimens of highly active antiretroviral therapy for HIV infection. Antiviral therapy 2004; 9:263-74.
Apr 1, 2004Long-term virological response to multiple sequential regimens of highly active antiretroviral therapy for HIV infection
Apr 1, 2004Antiviral therapy 2004; 9:263-74
Kaufmann Gilbert R, Battegay Manuel, Hirschel Bernard, Rickenbach Martin, Bernasconi Enos, Vernazza Pietro, Ledergerber Bruno, Cavassini Matthias, Furrer Hansjakob, Perrin Luc, Weber Rainer, Khanna Nina, Swiss HIV Cohort Study
Prevalence of unsafe sexual behavior among HIV-infected individuals: the Swiss HIV Cohort Study
Wolf K, Bucher H, Weber R, Telenti A, Hirschel B, Bernasconi E, Furrer H, Flepp M, Vernazza P, Rickenbach M, Young J, Swiss HIV Cohort Study. Prevalence of unsafe sexual behavior among HIV-infected individuals: the Swiss HIV Cohort Study. Journal of acquired immune deficiency syndromes (1999) 2003; 33:494-9.
Aug 1, 2003Prevalence of unsafe sexual behavior among HIV-infected individuals: the Swiss HIV Cohort Study
Aug 1, 2003Journal of acquired immune deficiency syndromes (1999) 2003; 33:494-9
Wolf Katja, Bucher Heiner C, Weber Rainer, Telenti Amalio, Hirschel Bernard, Bernasconi Enos, Furrer Hansjakob, Flepp Markus, Vernazza Pietro, Rickenbach Martin, Young James, Swiss HIV Cohort Study
A prospective trial of structured treatment interruptions in human immunodeficiency virus infection
Fagard C, Price D, Dawson S, Klimkait T, Perneger T, McLean A, Clotet B, Gatell J, Perrin L, Plana M, Phillips R, Hirschel B, Yerly S, Leduc D, Oxenius A, Günthard H, Garcia F, Le Braz M, Mestre G, Battegay M, Furrer H, Vernazza P, Bernasconi E, Telenti A, Weber R, Swiss HIV Cohort Study. A prospective trial of structured treatment interruptions in human immunodeficiency virus infection. Archives of internal medicine 2003; 163:1220-6.
May 26, 2003A prospective trial of structured treatment interruptions in human immunodeficiency virus infection
May 26, 2003Archives of internal medicine 2003; 163:1220-6
Fagard Catherine, Price David, Dawson Sara J, Klimkait Thomas, Perneger Thomas V, McLean Angela, Clotet Bonaventura, Gatell Jose M, Perrin Luc, Plana Montserrat, Phillips Rodney, Hirschel Bernard, Yerly Sabine, Leduc Dominique, Oxenius Annette, Günthard Huldrych, Garcia Felipe, Le Braz Michelle, Mestre Gabriel, Battegay Manuel, Furrer Hansjakob, Vernazza Pietro, Bernasconi Enos, Telenti Amalio, Weber Rainer, Swiss HIV Cohort Study
Abnormalities of body fat distribution in HIV-infected persons treated with antiretroviral drugs: The Swiss HIV Cohort Study
Bernasconi E, Telenti A, Rickenbach M, Weber R, Opravil M, Chave J, Boggian K, Hirschel B, Haensel A, Furrer H, Flepp M, Junghans C, Boubaker K, Swiss HIV Cohort Study. Abnormalities of body fat distribution in HIV-infected persons treated with antiretroviral drugs: The Swiss HIV Cohort Study. J Acquir Immune Defic Syndr 2002; 31:50-5.
Sep 1, 2002Abnormalities of body fat distribution in HIV-infected persons treated with antiretroviral drugs: The Swiss HIV Cohort Study
Sep 1, 2002J Acquir Immune Defic Syndr 2002; 31:50-5
Bernasconi Enos, Telenti Amalio, Rickenbach Martin, Weber Rainer, Opravil Milos, Chave Jean-Philippe, Boggian Katia, Hirschel Bernard, Haensel Alexander, Furrer Hans-Jakob, Flepp Markus, Junghans Cornelia, Boubaker Karim, Swiss HIV Cohort Study
A randomized trial of simplified maintenance therapy with abacavir, lamivudine, and zidovudine in human immunodeficiency virus infection
Opravil M, Perrin L, Weber R, Howe C, Günthard H, Ledergerber B, Battegay M, Bernasconi E, Vernazza P, Fischer M, Bisset L, Yerly S, Chave J, Furrer H, Lazzarin A, Hirschel B, Swiss HIV Cohort Study. A randomized trial of simplified maintenance therapy with abacavir, lamivudine, and zidovudine in human immunodeficiency virus infection. The Journal of infectious diseases 2002; 185:1251-60.
May 1, 2002A randomized trial of simplified maintenance therapy with abacavir, lamivudine, and zidovudine in human immunodeficiency virus infection
May 1, 2002The Journal of infectious diseases 2002; 185:1251-60
Opravil Milos, Perrin Luc, Weber Rainer, Howe Colin, Günthard Huldrych, Ledergerber Bruno, Battegay Manuel, Bernasconi Enos, Vernazza Pietro, Fischer Marek, Bisset Leslie R, Yerly Sabine, Chave Jean-Philippe, Furrer Hansjakob, Lazzarin Adriano, Hirschel Bernard, Swiss HIV Cohort Study